TLR9 and Alzheimer disease: We performed additional experiments to assess the effects of TLR9 signaling on the macrophage/microglia activation state and their ability to promote phagocytosis, on a more acute basis, in order to assess the mechanisms by which CpG ODN treatment could lead to AD pathology reduction.